Investigative Medicine Division
We aim to rapidly translate innovative science into patient benefit across a range of disease areas. From molecular biology and target discovery, through to interventional medicine and informing policy, we bring together researchers in a diverse range of specialties including acute stroke, dementia and immunology.
Head of Division
Latest publications
-
Stroke in the Time of Circadian Medicine.
Journal article
Mergenthaler P. et al, (2024), Circ Res, 134, 770 - 790
-
Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19.
Journal article
Hanson AL. et al, (2024), Nat Immunol, 25, 471 - 482
-
A high-throughput two-cell assay for interrogating inhibitory signaling pathways in T cells.
Journal article
Sharma S. et al, (2024), Life Sci Alliance, 7
-
Fatigue after CriTical illness (FACT): Co-production of a self-management intervention to support people with fatigue after critical illness.
Journal article
Brown SE. et al, (2024), Intensive Crit Care Nurs, 82
-
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in psoriasis: a systematic review and meta-analysis.
Journal article
Ye JH. et al, (2024), Arch Dermatol Res, 316
COVID-19 research
Novel all-in-one vaccine developed to tackle future coronavirus threats
6 July 2022
Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.
Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease
1 December 2021
Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
What's new
Welcome to the new RDM Visiting Professors
27 November 2023